Want to join the conversation?
Biopharmaceutical company $EBS said that it received a favorable private letter ruling from the Internal Revenue Service (IRS) associated with the planned spin-off of its biosciences business. Subject to terms, the ruling confirms that certain aspects of the planned transaction will not preclude the spin-off from qualifying as tax-free to $EBS.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.